SFM
SKYE icon

Sphera Funds Management’s Skye Bioscience SKYE Stock Holding History

Sphera Funds Management’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$417K Buy
678,928
+200,000
+42% +$163K 0.07% 93
2025
Q4 		$359K Hold
478,928
– – 0.07% 93
2025
Q3 		$1.88M Sell
478,928
-59,506
-11% -$225K 0.4% 74
2025
Q2 		$2.25M Sell
538,434
-937,919
-64% -$1.94M 0.53% 62
2025
Q1 		$2.35M Sell
1,476,353
-88,275
-6% -$241K 0.54% 57
2024
Q4 		$4.43M Buy
1,564,628
+1,106
+0.1% +$4.62K 0.8% 45
2024
Q3 		$6.11M Buy
1,563,522
+265,210
+20% +$1.49M 0.97% 37
2024
Q2 		$10.4M Buy
+1,298,312
New +$15.4M 1.42% 23

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sphera Funds Management's SKYE Position: Q1 2026 in Review

Sphera Funds Management increased its Skye Bioscience (SKYE) stake by 42% in Q1 2026, buying an estimated $163K and bringing the position to 678,928 shares worth $417K. The position accounts for 0.07% of the portfolio, ranked #93.

Sphera Funds Management first reported a position in SKYE in Q2 2024 and has held it in 8 quarters since. The position peaked at $10.4M in Q2 2024. 39 funds tracked by Wall St. Rank hold SKYE as of Q1 2026.

  • Sphera Funds Management held 678,928 shares of Skye Bioscience worth $417K as of Q1 2026.
  • Sphera Funds Management bought 200,000 Skye Bioscience shares in Q1 2026, an estimated $163K.
  • Skye Bioscience made up 0.07% of Sphera Funds Management's portfolio in Q1 2026, its #93 holding.
  • Sphera Funds Management first reported a position in Skye Bioscience in Q2 2024 and has held it in 8 quarters since.
  • Sphera Funds Management's Skye Bioscience position peaked at $10.4M in Q2 2024.
  • 39 funds tracked by Wall St. Rank held Skye Bioscience as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.